SUBSCRIBE
SUBSCRIBE

Metacrine, Inc.

NEWS
Business
Elevian Launches to Join Numerous Companies Focused on Longevity and Aging
In another example of companies focused on aging-related diseases, Elevian launched with $5.5 million in seed funding. Elevian’s founders came out of Stanford and then Harvard, focused on regenerative effects of “young blood.”
September 7, 2018
 · 
3 min read
 · 
Mark Terry
Load More
AWARDS
  • NextGen Class of 2016
JOBS
IN THE PRESS
Deals
Equillium and Metacrine Mutually Agree to Terminate Definitive Merger Agreement
December 23, 2022
 · 
5 min read
Deals
Metacrine and Equillium Mutually Agree to Terminate Definitive Merger Agreement
December 23, 2022
 · 
2 min read
Business
Metacrine Reports Third-Quarter 2022 Results
November 14, 2022
 · 
7 min read
Deals
Equillium to Acquire Metacrine in All-Stock Transaction
September 6, 2022
 · 
13 min read
Business
Metacrine Reports Second-Quarter 2022 Results
August 9, 2022
 · 
5 min read
Business
Metacrine Reports First-Quarter 2022 Results
May 12, 2022
 · 
6 min read
Business
Metacrine Reports Fourth-Quarter 2021 Results
March 30, 2022
 · 
5 min read
Business
Metacrine Announces Executive Leadership Changes
February 24, 2022
 · 
2 min read
Drug Development
Metacrine Updates IBD Clinical Development Strategy and Implements Restructuring Plan
February 11, 2022
 · 
4 min read
Business
Metacrine Announces Resignation of Chief Medical Officer
December 27, 2021
 · 
2 min read
Load More